Alland Leila
SEC Form 4 insider trading activity
Alland Leila has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, Alland Leila is listed as Director at ABEONA THERAPEUTICS INC. Inside the rolling window, Alland Leila reported no open-market purchases and 2 open-market sales totaling $157K in ABEO. The largest disclosed transaction in the window is a sale of 18,065 ABEO shares on Feb 2, 2026, worth $92K.
Companies traded
Other insiders at ABEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$157K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Alland Leila made?
Alland Leila has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Alland Leila trade?
Alland Leila has filed SEC Form 4 disclosures for 1 company, including ABEO.
When was Alland Leila's most recent SEC Form 4 filing?
Alland Leila's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is Alland Leila's total buy and sell value in the current window?
Inside the rolling retention window, Alland Leila bought $0 and sold $157K based on SEC Form 4 filings.
What was Alland Leila's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,065 ABEO shares on 2026-02-02, worth $92K, per SEC Form 4 filings.